Clinical Trials Logo

Advanced Solid Tumor Cancers clinical trials

View clinical trials related to Advanced Solid Tumor Cancers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01208831 Completed - Clinical trials for Basal Cell Carcinoma

An East Asian Study of LDE225

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine Maximum Tolerated Dose (MTD) or recommended phase II dose of LDE225 when administered orally to two adult patient groups of East Asian (i.e., Japanese and Chinese/Taiwanese) with advanced solid tumors that have progressed despite standard therapy or for which no standard therapy exists.

NCT ID: NCT00880308 Completed - Clinical trials for Basal Cell Carcinoma

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Start date: March 2009
Phase: Phase 1
Study type: Interventional

This first-in-human dose-escalation study is to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of LDE225 given orally on a daily dosing schedule in patients with advanced solid tumors.